Chibuzor Ogamba

Chibuzor started his DPhil in 2024 and his DPhil project is supervised by Dr. Karl Smith-Byrne, Professor Ruth Travis and Professor Gillian Reeves, and funded by an NDPH studentship. His research is focused on investigating the efficacy and safety of repurposing existing drugs for the prevention of a wide variety of cancers using large-scale proteogenomic data and cancer endpoints in the UK Biobank, EPIC, the Million Women Study and the All of Us Research Project as well as other available GWAS data. 

Before this, Chibuzor completed a degree in medicine and surgery at the University of Lagos, Nigeria in 2018, and subsequently, an MSc in Global Health Science and Epidemiology from Oxford Population Health in 2023, funded by an NDPH studentship. His MSc dissertation was focused on developing a system for rational drug prioritisation using information from drug label databases and leveraging available protein quantitative trait loci (pQTLs) from large proteomics datasets to investigate the repurposing potential of prioritised drugs for the therapeutic prevention of colorectal, lung, breast, prostate cancer, and multiple myeloma using drug target Mendelian randomisation. 

After his MSc, he joined the Cancer Epidemiology Unit (CEU) as a Trainee Fellow in 2023. Chibuzor previously worked as a research associate at the NSIA-LUTH Cancer Centre in Lagos, Nigeria, and actively conducted epidemiological studies in Nigeria.